FIELD: medicine, endocrinology, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to using a biologically active compound representing succinic acid para-aminobenzoyl hydrazide as a medicinal immunomodulating preparation. The proposed compound provides recovery of phagocytic activity of neutrophiles up to normal values on background of immunodeficiency.
EFFECT: valuable medicinal property of compound.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
MALEIC ACID 3-METHYL-2-PYRIDYLAMIDE ELICITING DIRECT ANTICOAGULANT EFFECT | 2005 |
|
RU2294199C2 |
TETRACHLOROPHTHALIC ACID 4-METHYL-2-PYRIDYLAMIDE ELICITING HYPERTENSIVE ACTIVITY | 2002 |
|
RU2227797C2 |
MALEIC ACID 4-METHYL-2-PYRIDYLAMIDE ELICITING HYPERTENSIVE ACTIVITY | 2003 |
|
RU2247721C2 |
CITRACONIC ACID ISONICOTINOYLHYDRAZIDE ELICITING HYPOGLYCAEMIC ACTIVITY | 2000 |
|
RU2183625C2 |
N-ISOPROPYLAMIDE 2-(6,7-DIMETHOXY-3-SPIRO-CYCLOPENTYL-3,4-DIHYDROISOQUINOLYL-1)-ETHANOIC ACID HYDROCHLORIDE, WHICH POSSESSES HYPERTENSIVE ACTIVITY | 2010 |
|
RU2491277C2 |
N-(4-CHLOROBENZOYL)-5-BROMOANTHRANYL ACID AMID EXHIBITING ANTI-INFLAMMATORY AND ANALGETIC ACTIVITIES | 2003 |
|
RU2247717C2 |
2-(2,4-DICHLORANILINO)-1,4-BIS(4-METHYLPHENYL)-2-BUTEN-1,4-DION, POSSESSING ANTIMICROBIAL ACTIVITY | 2008 |
|
RU2396249C2 |
ISONICOTINOYLHYDRAZIDE PHTHALATE AS ANTIDIABETIC AGENT | 2006 |
|
RU2331418C2 |
2-HYDROXY-N-(6-METHOXYBENZO[D]THIAZOL-2-YL)-4-OXO-4-PHENYLBUT-2-ENAMIDE, HAVING GASTROPROTECTIVE AND IMMUNOMODULATORY ACTION | 2018 |
|
RU2723897C2 |
2-HYDROXY-5,5-DIMETHYL-4-OXO-2-HEXENOIC ACID N-41-METHYL-21-PYRIDYLAMIDE ELICITING HYPERTENSIVE ACTIVITY | 2004 |
|
RU2264390C1 |
Authors
Dates
2007-07-27—Published
2004-12-16—Filed